Events | GileadPro

Reflections on the BSH guidelines for R/R LBCL

Presented by Dr Sridhar Chaganti & Dr Cathy Burton
Join two of the BSH Guideline authors, Dr Sridhar Chaganti and Dr Cathy Burton, as they break down the latest BSH guidelines (May 2025) for the management of relapsed/refractory large B-cell lymphoma (R/R LBCL).

In this insightful Talking Heads video, our presenters explore the key updates, clinical implications, and practical considerations for implementing the new recommendations across the UK. Whether you're a haematologist, oncologist, nurse specialist, or healthcare professional involved in lymphoma care, this video offers guidance and expert commentary to help you stay ahead in your practice.

Kite National Webinar: Patient selection and CAR T-cell therapy 5 years on

In this webinar Dr Wendy Osborne, Dr Robin Sanderson and Dr Kawai Yip [Skye] are discussing five years of chimeric antigen receptor T-cell (CAR T-cell) therapy, and the considerations of expanding patient selection.

Kite Webinar on DLBCL Treatment: Practical Guidance to Optimise Patient Outcomes

The availability of 2L CAR T for eligible patients with R/R DLBCL within 12 months from 1L chemoimmunotherapy is a milestone in this setting. Dr Sridhar Chaganti, Dr Kate Cwynarski and Dr Michael Jain outline these important changes to the DLBCL treatment landscape, explain the data that drove this decision and offer guidance on providing optimal treatment to patients.